‡ In these countries please contact our distributor

MolecuLight i:X

The MolecuLight i:XTM  Wound Imaging Device is not available through
Smith+Nephew in the USA


Instant detection of wound bioburden*

Bacterial fluorescence imaging facilitates intelligent, targeted wound management1-3

The MolecuLight i:XTM Imaging Device offers instant visualisation of bacterial  fluorescence, guiding clinicians to facilitate precise debridement1-3 and help get wounds with a moderate to heavy bacteria level on the path to healing.

Through real-time fluorescence imaging, this wound intelligence device seeks to optimise many aspects of wound care, including infection management.

Hand-held and easy-to-use4, the MolecuLight i:XTM Imaging Device has shown potential to optimise wound bed preparation (cleaning and debridement), guide treatment choice and track bioburden* when incorporated into standard care1,2,5-8.


Take the MolecuLight Inc training certification module >


  Contact-free assessment of moderate to high levels of fluorescent bacteria, guiding treatment decisions across various wound types1,8.
  Real-time flourescent bacterial assessment, including common wound pathogens, in a variety of wounds1,6,7.


View our full evidence collection


You need to see this

We’re offering a 4-week, no-obligation trial of the MolecuLight i:XTM Imaging Device to experience the difference it can make to your staff and patients.

Ask a Smith & Nephew representative to arrange a trial

T.I.M.E. to help prevent infection

Advanced wound management clinical decision support tool

Wound management is a highly complex issue, so we’ve compiled a clinical decision support tool to help you choose the right treatment, for the right wound, at the right time.

View our T.I.M.E. clinical decision support tool


Visualise moderate to heavy levels of bacterial flourescence with the MolecuLight i:XTM Imaging Device1.  

Where localised infection is detected, use an antimicrobial dressing for 2 weeks9. Continue use if there is improvement, but discontinue if infection clears or the wound stalls9.

Try: ACTICOAT Antimicrobial Barrier Dressing with nanocrystalline silver.


Biofilm is present in 78% of chronic wounds10 and may delay healing11. Once identified, treat with a topical antimicrobial.

Try: IODOSORB Cadexomer Iodine dressings and topical products.

Helping you get CLOSER TO ZERO barriers to wound healing.


*The MolecuLight i:X Imaging Device detects moderate to heavy levels of fluorescent wound bacteria.


AWM AWD 16553



1) DaCosta RS, Kulbatski I, Lindvere-Teene L et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19; 10(3).
2) Blumenthal E, Jeffery S. Auto fluorescence imaging for evaluating debridement in military and trauma wounds. Mil Med. 2018; 183:429-432.
3) Kim P.J, Attinger C.E, Bigham T.B, et al. Clinic-based Debridement of Chronic Ulcers Has Minimal Impact on Bacteria. Wounds : a compendium of clinical research and practice. 2018;30(5):138-143.
4) Blumenthal E, Jeffery S. The Use of the MolecuLight i:X in Managing Burns: A Pilot Study. American Burn Association. 2017.
5) Landis SL, Rennie MY, Blumenthal E, Jeffery S. Use of fluorescence imaging in visualizing bacteria in chronic ulcers and traumatic soft tissue damage. Proceedings of the Annual Meeting of the Society of Federal Health Professionals (AMSUS); 2016 Nov 29-Dec 2; National Harbor, MD.
6) Ottolino-Perry K, Chamma E, Blackmore KM, et al. Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers. Int Wound J. 2017; doi: 10.1111/iwj.12717.
7) Rennie M.Y, Lindvere-Teene L, Tapang K, Linden R. Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. Journal of Wound Care. 2017; 26(8).
8) Hill R, Douglas JJ. Using Bacterial Fluorescence Imaging and Antimicrobial Stewardship to Guide Wound Management Practices: A Case Series. Ostomy Wound Management, 2018, 64(8), 18–28.
9) International consensus. Appropriate use of silver dressings in wounds. An expert working group consensus. London: Wounds International, 2012.
10) Wound Rep Reg (2017) 25 744–757. Malone, M., Bjarnsholt, T., McBain, A.J. et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data, J. Wound Care 2016; vol 25, no 12.
11) Schultz, G., Bjarnsholt, T., Garth A. James, G.A., Leaper, D.j., McBain, A.j. et al for the Global Wound Biofilm Expert Panel. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds.

Contact us about the MolecuLight i:XTM Imaging Device

Get in touch

The MolecuLight i:XTM Imaging Device
is manufactured by
MolecuLight Inc.

Moleculight Logo

Learn more